Slide 1

October 9, 2020

Over the next few months, GMT will sponsor several phased clinical trials including Adults with confirmed COVID 19 here in the US.
Image is not available

The entire world is at an unprecedented impasse collecting scientific data as rapidly as possible to enable a treatment process that will stop the onslaught of COVID19 infections. Regardless the advancements on vaccines or drug therapy, PCI technology has enough scientific sustainability.

Slide 2

Sept 12th, 2018

Image is not available
PCI- I: Advanced bio medical technology dedicated to the treatment of Catastrophic diseases.

Our company intends to use its proprietary biomedical technologies to be a leader in the development of Photonic biomedical technologies, systems, machinery, products and multiple applications. GMT seeks to expand their outreach of its proprietary Photonic Corpuscular Irradiation (“PCI”) biomedical technology that will innovate and advance the frontiers of medical scientific inquiry as we know it.

Slide 3

Sept 12th, 2018

GMT has developed a treatment modality which effectively inactivates viruses, bacteria’s, fungus and parasites in the blood stream.
Image is not available

To Date; GlobalMed Technologies (GMT); is the only Company, Entity to perform any International Government Approved Controlled Clinical Trials on HIV/AIDS utilizing Low Ultraviolet Irradiation. GMT performed Phase I Controlled Clinical Trial in 36 patients with HIV/AIDS in the Dominican Republic in 2004-2005.

Slide 4

July, 17th 2018

GMT has Academic and Government approval to conduct Controlled Clinical Trials in South America for HIV/AIDS.
Image is not available

Performing clinical trials demonstrates the company's openness to prove its science is safe, viable and effective. These Trials performed in South America and other developing countries follow the exact guidelines instilled by the FDA in the US and the IHC Standardized Worldwide Guidelines for Clinical Trials.

previous arrowprevious arrow
next arrownext arrow

Breakthrough Discovery in the Treatment of HIV/Aids and other Catastrophic Diseases.

Fifteen years ago, Dr. Danilo Fernandez discovered an innovative way of treating all types of viral, bacterial, fungal and parasitic diseases that afflict both humans and animals.

In 2002 he designed a machine that treats the blood in such a way that it eliminates all pathogens from the blood.


Our Bio Medical Treatment Modality

Photonic Corpuscular Irradiation (PCI) clinical trials proving to dramatically improve Human & Animal Health, while reducing Healthcare costs by up to 90%.

In 2003 Dr. Danilo Fernandez received a U.S. patent for his product and process. In 2004 a government approved, Phase I Controlled Clinical Trial was conducted on 36 patients with acute and chronic HIV/AIDS. These patients’ viral loads were reduced by 85 to 99% and their CD4-cells (T-helper cells) were stabilized and reduced. Most importantly, 100% of opportunistic infections were eliminated and none of these patients were given anti-viral medications, either prior to or during the trial. Between 2006 and 2009, we completed an additional pilot study on 7 patients, in order to prove and repeat the results achieved in Phase I.  We not only surpassed our earlier results, but we also showed that the 7 Chronic HIV patients (who had been hospitalized between 5 to 7 times a year in the past) did not require hospitalization or any anti-retroviral medications, for the duration of the 29-month study.
To our success, we were able to demonstrate extraordinary results in our Phase I Clinical Trials, to the best of our knowledge; no one has come as close as we have with our treatment modality, to providing a cure for HIV/AIDS.  With certainty we can safely say that we believe that our treatment reduces the costs associated with keeping a person with HIV alive by 90%, this is critical to every under-developed and developing countries HIV patient(s) outreach and  medical treatment. Our proprietary biomedical treatment system can be utilized to effectively treat HIV.AIDS as described herein our site. Similarly, we believe in our treatments efficacy against all viral diseases including influenza and Ebola, Staphylococcus (Staph infection) such as MRSA: narcotizing fasciitis (flesh eating bacteria), Avian Flu, Swine Flu and some 75 other diseases as well as 60 veterinary diseases like Laminitis (second leading cause of death in horses and cattle).  More

Questions That Have Become Our Call to Action

An epidemic occurs when a disease affects a greater number people than is usual for the locality or one that spreads to areas not usually associated with the disease. A pandemic is an epidemic of world-wide proportions.

You Are Our Purpose

We are dedicated to making our treatment readily available to People  all over the World from all walks of life , that are either allergic or resistant to  Anti-retroviral’s,  We can increase the quality of your Life with our treatment.

"Right To Try Act"

On May 30, 2018, President Donald Trump signed S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn and Matthew Bellina Right to Try Act.  We encourage terminally ill persons,  to look into other medical  treatment  options after they have exahausted all other avenues.

Human Applications

GMT has developed several specific treatment regiments for: HIV/AIDS, Leishmaniasis, Dengue, Malaria, Zika Virus, Ebola, SAR-CoV-2, and Necrotizing Fasciitis (“flesh-eating bacteria.”)

Veterinary Applications

GMT has developed several specific treatment modalities to treat Animals : Laminitis,  Founders disease, Equine HIV, Parvo, Mad Cow, Swine Flu and Avian Flu

Our Accomplishments

  • GMT has developed a treatment modality which effectively inactivates the HIV virus.
  • GMT has successfully completed a Pilot Study which lasted 29 months, demonstrating a reduction in viral loads comparable to that of medications used and a Phase I Clinical Trial
  • GMT has Academic and Government pre approval to conduct Clinical Trials in Leishmaniasis, Laminitis/Founders Disease, Zika and Lyme Disease.
  • GMT has also developed a Blood Irradiation Process for the Sterilization of Blood Elements.
  • GMT has also developed a Blood Irradiation System for the Transplants of Organs and Anti-Immune rejection.


  • GMT has proven to Reduce Costs; from $100,000 per year to $10,000, a 90% reduction across the board in costs.GMT has patented it’s process, products and technology.
  • GMT manufactures it’s 5 main components :
    • PCI-I: Hemoirradiator.
    • The GMT – Electronic master control card
    • GMT – Proprietary Software
    • Patient Intelli – Flash Drive Software
    • The GMT – Cuvette, (Irradiation Chamber)

HIV/AIDS: Statistics

New HIV Infections daily (Age 0-14) per day

Aids-related deaths per day

New HIV Infections (total) per day

Lives that could have been saved by our Treatment since the year 2000

HIV Additional Resources

  • UNAIDS; REPORT on the global HIV/AIDS epidemic, June 2000
  • KAISER FAMILY FOUNDATION; The Global HIV/AIDS Epidemic, July 25,2018
  • WORLD HEALTH ORGANIZATION; 2017 Data and statistics

Our Mission

GlobalMed Technologies USA ("GMT"), intends to use its proprietary biomedical technologies to be a leader in the development of Photonic biomedical technologies, systems, machinery, products and multiple applications. GMT seeks to expand their outreach of its proprietary Photonic Corpuscular Irradiation (“PCI”) biomedical technology that will innovate and advance the frontiers of medical scientific inquiry as we know it.

GMTUSA,  Your Ally During The COVID19 Pandemic

GMTUSA, Your Ally During The COVID19 Pandemic

PCI FOR COVID-19 is an international, multi-site, IRB approved clinical trial created to establish an effective treatment for COVID-19, it was launched by GlobalMed Technologies USA “GMT” and partners. The PCI FOR COVID trial compares options against standard care to...

Expanding Our Veterinary Outreach

Expanding Our Veterinary Outreach

We are delighted to inform you that GMT will be expanding its Veterinarian Outreach program here in the United States.  In past years,  we have primarily provided our biomedical medical treatment to both horses and...

GMT Fundraising Campaign

GMT Fundraising Campaign

GlobalMed Technologies USA has launched its own crowdfunding platform under Regulation D, Rule 506(c), solely directed to accredited Investors.  We are leaders in the development of Photonic biomedical technologies, systems, machinery, products and multiple...

What Customers Say

Scott Rishel


In all my life’s experience with health problems and treatments, this one showed immediate results.   No unpleasant side effects.  Wow! Wow! Wow!


Ms. Nelly


Ms. Nelly was suffering from Founders Disease,  she was struggling to breathe and she could no longer stand up.  After two treatments, she was perfectly fine and healthy again.  My Veterinarian was shocked at how well my mare responded to the treatment. 

    Tabitha Varela

Owner of Ms Nelly

Ben Grafton

Dr Fernandez and I go back 44+ years... so, as you can imagine I was one of Dan's first patients... Years ago, I was suffering from a really bad flu, including aches, pains, coughing, sinus congestion and high fever...The norm for a bad flu... Six hours later after one 20 minute treatment and no medication, it was gone. Really gone... This Really Works!



Testimony from Mariano Roldan Perez

I have lived with HIV for over 26 years, I have traveled the world and tried every Treatment and Anti Viral Cocktail.  Ten days I started Dr. Danilo's treatment I stoped taking all medication. Since his treatment I have not even had an aspirin.  I have notice a tremendous change in my entire Organism, my apetite has returned, my Candidiasis and issues with my prostate have all disappeared after just 20 days of treatment. I believe that this treatment is not only good for HIV infected people, it is good for all of humanity.

Ready to get started?

For more information about how our biomedical treatment can help you or some one you love or if you just want to be part of our amazing journey, please feel free to contact us by clicking on  contact us.  We look forward to hearing from you.